![Ann Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Lee
Directeur Technique/Scientifique/R&D chez
PRIME MEDICINE, INC.
Fortune : 365 237 $ au 31/07/2026
Profil
Dr. Ann L.
Lee is a Chief Technical Officer at Prime Medicine, Inc., an Independent Director at Coya Therapeutics, Inc., a Member at National Academy of Engineering and a Member at Washington State Academy of Sciences.
She is on the Board of Directors at Coya Therapeutics, Inc., Alliance for Regenerative Medicine, American Institute of Chemical Engineers and JW Therapeutics (Shanghai) Co., Ltd. Dr. Lee was previously employed as a SVP, Head of Cell Therapy Development & Operations by Bristol Myers Squibb Co., an EVP-Cell Therapy Development & Operations by Celgene Corp., an Executive Vice President-Technical Operations by Juno Therapeutics, Inc., a SVP & Head-Global Technical Development by Roche Corp., a SVP, Global Head-Pharma Technical Development by Genentech, Inc., a VP-Process Engineering & Technical Operations by Merck & Co., Inc., and a VP-Chemical Technology & Engineering by Merck Research Laboratories Massachusetts LLC.
She also served on the board at JW (Cayman) Therapeutics Co. Ltd. She received her undergraduate degree from Cornell University, a graduate degree from Yale University and a doctorate degree from Yale University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRIME MEDICINE, INC. 0,06 % | 31/03/2026 | 100 000 ( 0,06 % ) | 292 000 $ | 31/07/2026 |
COYA THERAPEUTICS, INC. 0,07 % | 01/05/2026 | 17 479 ( 0,07 % ) | 73 237 $ | 31/07/2026 |
Postes actifs de Ann Lee
| Sociétés | Poste | Début |
|---|---|---|
| PRIME MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 01/10/2021 |
| COYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2021 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Membre du Conseil | - |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Directeur/Membre du Conseil | - |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
American Institute of Chemical Engineers
 American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Directeur/Membre du Conseil | - |
Washington State Academy of Sc
 Washington State Academy of Sc Miscellaneous Commercial ServicesCommercial Services Washington State Academy of Sciences (WSAS) is a nonpartisan, independent scientific advisory organization established by state law in 2005 to provide objective, evidence-based scientific and technical information to state policymakers, including the legislature, state agencies, and the governor’s office. The private company is located in the US. WSAS operates as a nonprofit with a mission to inform public policy and enhance research impact through expert assessments, reports, and convenings. The organization mobilizes scientific and engineering experts to address state issues via studies, workshops, and peer-reviewed reports on topics such as clean energy, transportation resilience, salmon recovery, emerging contaminants, and the impacts of COVID-19. It organizes member-driven topical affinity groups to foster multidisciplinary collaboration on scientific and technological challenges relevant to the state. WSAS supports science education and the next generation of scientists through programs like the Washington Junior Academy of Sciences and is developing a science policy fellowship to connect scientists with policymakers. The "Growing with AI" initiative explores artificial intelligence applications to enhance the sustainability and economic viability of the state’s agricultural sector. | Corporate Officer/Principal | - |
Anciens postes connus de Ann Lee
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/07/2021 |
| CELGENE | Corporate Officer/Principal | 01/11/2019 |
| ░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Ann Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
American Institute of Chemical Engineers
American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Commercial Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Roche Corp. | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Washington State Academy of Sc
Washington State Academy of Sc Miscellaneous Commercial ServicesCommercial Services Washington State Academy of Sciences (WSAS) is a nonpartisan, independent scientific advisory organization established by state law in 2005 to provide objective, evidence-based scientific and technical information to state policymakers, including the legislature, state agencies, and the governor’s office. The private company is located in the US. WSAS operates as a nonprofit with a mission to inform public policy and enhance research impact through expert assessments, reports, and convenings. The organization mobilizes scientific and engineering experts to address state issues via studies, workshops, and peer-reviewed reports on topics such as clean energy, transportation resilience, salmon recovery, emerging contaminants, and the impacts of COVID-19. It organizes member-driven topical affinity groups to foster multidisciplinary collaboration on scientific and technological challenges relevant to the state. WSAS supports science education and the next generation of scientists through programs like the Washington Junior Academy of Sciences and is developing a science policy fellowship to connect scientists with policymakers. The "Growing with AI" initiative explores artificial intelligence applications to enhance the sustainability and economic viability of the state’s agricultural sector. | Commercial Services |
